Xencor | XNCR - Debt

Stock Price
11.22
Daily Change
-0.66 -5.56%
Monthly
-9.88%
Yearly
39.21%
Q2 Forecast
10.99

Xencor reported $187.75M in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Alnylam Pharmaceuticals USD 1.28B 30.06M Dec/2025
Amgen USD 54.6B 17M Dec/2025
Arrowhead Research USD 312.77M 53.52M Dec/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Biogen USD 6.56B 275.1M Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Cytokinetics USD 1.29B 4.48M Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
J&J USD 47.93B 2.14B Dec/2025
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
MacroGenics USD 37.01M 238K Sep/2025
Merck USD 49.34B 7.97B Dec/2025
Novartis USD 47B 11.62B Mar/2026
Pfizer USD 63.73B 231M Mar/2026
Regeneron Pharmaceuticals USD 2.71B 300K Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Xencor USD 187.75M 118.48M Dec/2025